Join episode host, Todd Eury, founder and CEO of the Pharmacy Podcast Network, as he discusses the indispensable role of pharmacists in T2D care with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP and Rohit Moghe, PharmD, MSPH, CDCES. These pharmacist experts will share insights on why the role of pharmacists is so important in T2D care, including reviewing data on how pharmacist involvement improves measurable outcomes for patients with T2D. To raise awareness, they will also review T2D treatment recommendations from major medical societies.

This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Faculty Presenters:

Todd Eury, BS
CEO
Pharmacy Podcast Network Brownsville, Pennsylvania

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology
The Cleveland Clinic Cleveland, Ohio

Rohit Moghe, PharmD, MSPH, CDCES
Ambulatory Care & Population Health Clinical Pharmacist
Trinity Health Mid-Atlantic Langhorne, Pennsylvania

What are the prevalence, increased risk, and impact of cardiovascular disease (CVD) among patients with type 2 diabetes (T2D)? Join experts: Dr John Anderson (primary care physician), Dr Pam Taub (cardiologist), and Dr Mark Greathouse (cardiologist) as they review the relationship between T2D and CVD, including how T2D exacerbates CVD and the risk from CVD, and what the national medical associations recommend for patients with T2D and CVD.

This podcast is sponsored by Novo Nordisk and is intended for clinicians.

Faculty Presenters:

John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee

Pam Taub, MD, FACC
Cardiologist and Professor of Medicine
Director, Cardiac Rehabilitation and Wellness Center
UC San Diego Health
San Diego, California

Mark Greathouse, MD
Senior Clinical Cardiologist
St. Clair Health
Pittsburg, Pennsylvania

What is the impact of insufficient GLP-1 activity in type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.

This podcast is sponsored by Novo Nordisk and is intended for clinicians.

Faculty Presenters:

John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee

Javier Morales, MD, FACP, FACE
Internal Medicine, Diabetes, and Primary Care
Associate Clinical Professor
Hofstra/Northwell School of Medicine at the Donald and Barbara Zucker School of Medicine
Long Island, New York

Richard E. Pratley, MD
Internal Medicine and Diabetes
AdventHealth Diabetes Institute
Orlando, Florida